---
figid: PMC7426584__gr10
figlink: pmc/articles/PMC7426584/figure/fig10/
number: F10
caption: The proposed signaling pathway activated by Mito-Met and other metformin
  analogs. As shown, Mito-Met activated AMPK phosphorylation via inhibition of mitochondrial
  complex I and ROS generation. Reprinted from Cheng G, Zielonka J, Ouari O et al.
  Mitochondria-Targeted Analogs of Metformin Exhibit Enhanced Antiproliferative and
  Radiosensitizing Effects in Pancreatic Cancer Cells. Cancer Res. 2016 Jul 1; 76
  (13):3904–15.
pmcid: PMC7426584
papertitle: 'Teaching the basics of repurposing mitochondria-targeted drugs: From
  Parkinson''s disease to cancer and back to Parkinson''s disease.'
reftext: Balaraman Kalyanaraman. Redox Biol. 2020 Sep;36:101665.
pmc_ranked_result_index: '2026'
pathway_score: 0.9531921
filename: gr10.jpg
figtitle: Proposed signaling pathway activated by Mito-Met and other metformin analogs
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7426584__gr10.html
  '@type': Dataset
  description: The proposed signaling pathway activated by Mito-Met and other metformin
    analogs. As shown, Mito-Met activated AMPK phosphorylation via inhibition of mitochondrial
    complex I and ROS generation. Reprinted from Cheng G, Zielonka J, Ouari O et al.
    Mitochondria-Targeted Analogs of Metformin Exhibit Enhanced Antiproliferative
    and Radiosensitizing Effects in Pancreatic Cancer Cells. Cancer Res. 2016 Jul
    1; 76 (13):3904–15.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MFAP1
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - metformin
  - 2-OH
  - NAD
  - FADH
  - AMP
  - ATP
genes:
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
chemicals:
- word: metformin
  source: MESH
  identifier: D008687
- word: 2-OH
  source: MESH
  identifier: C031356
- word: NAD
  source: MESH
  identifier: D009243
- word: FADH
  source: MESH
  identifier: C058805
- word: AMP
  source: MESH
  identifier: D000249
- word: ATP
  source: MESH
  identifier: D000255
diseases: []
figid_alias: PMC7426584__F10
redirect_from: /figures/PMC7426584__F10
figtype: Figure
---
